Sexually transmitted infections (STIs) are a significant public health concern in Kenya, with the World Health Organization estimating that there are around 800,000 new cases of curable STIs each year. Early detection and treatment are crucial to prevent complications and further transmission. This article provides an overview of STI treatment guidelines in Kenya, focusing on the most common infections.

Kenya's Ministry of Health follows the World Health Organization's (WHO) guidelines for the treatment of STIs. The guidelines aim to reduce the burden of STIs, prevent their complications, and control their spread. They are based on the best available evidence and are regularly updated to reflect new research and drug resistance trends.

Common STIs in Kenya and Their Treatment
Kenya faces a high burden of STIs, with the most common being syphilis, gonorrhea, chlamydia, and trichomoniasis. HIV, while not curable, is also a significant concern and is often co-infected with other STIs. The following sections outline the treatment guidelines for these infections.

It's essential to note that these guidelines are for symptomatic patients. Asymptomatic patients may also be treated, especially in high-risk groups or when there's a high prevalence of STIs in the community.
Syphilis

Syphilis is caused by the bacterium Treponema pallidum and can be divided into primary, secondary, and tertiary stages. The treatment depends on the stage of infection. Penicillin is the first-line treatment for all stages of syphilis. For primary, secondary, and early latent syphilis, a single intramuscular injection of benzathine penicillin G is recommended. For late latent syphilis and tertiary syphilis, three such injections at weekly intervals are advised.
In case of penicillin allergy, doxycycline or tetracycline can be used as alternatives. However, these drugs are less effective and have more side effects than penicillin. It's crucial to follow up with patients after treatment to monitor for treatment failure or reinfection.
Gonorrhea and Chlamydia

Gonorrhea and chlamydia are often co-infected and can cause similar symptoms. The first-line treatment for both infections is ceftriaxone, a third-generation cephalosporin antibiotic, given as a single intramuscular injection. This is combined with azithromycin, a macrolide antibiotic, to treat both infections effectively.
This dual therapy is recommended to prevent the emergence of drug-resistant strains of gonorrhea. It's also crucial to treat sexual partners to prevent reinfection. Patients should be advised to abstain from sexual activity for seven days after treatment to prevent reinfection or transmission.
HIV and STI Co-infection

HIV is often co-infected with other STIs, which can increase HIV viral load, accelerate HIV disease progression, and facilitate HIV transmission. Therefore, HIV testing and counseling should be offered to all patients attending STI clinics. Antiretroviral therapy (ART) should be initiated as soon as possible in HIV-positive patients, regardless of their CD4 count.
ART has been shown to reduce HIV viral load to undetectable levels, preventing HIV transmission and improving the health of the individual. It's also crucial to treat other STIs in HIV-positive patients to prevent their complications and further HIV transmission.




















Trichomoniasis
Trichomoniasis is caused by the protozoan parasite Trichomonas vaginalis and is often asymptomatic in men but can cause vaginitis in women. The first-line treatment is metronidazole, a nitroimidazole antibiotic, given as a single oral dose. Metronidazole should also be given to the sexual partner to prevent reinfection.
It's important to note that metronidazole can cause disulfiram-like reactions when consumed with alcohol. Patients should be advised to avoid alcohol for at least 24 hours after treatment. If metronidazole is contraindicated, tinidazole can be used as an alternative.
Regular STI screening and treatment are crucial in reducing the burden of STIs in Kenya. Healthcare providers should follow these guidelines to ensure effective treatment and prevention of STIs. It's also essential to educate the public about STIs, their prevention, and the importance of regular screening and treatment. By working together, we can reduce the impact of STIs in Kenya.